DUBLIN--(BUSINESS WIRE)--Nov 3, 2022--
The "In-vitro Diagnostics Market Analysis by Product & Service, by Technology, by Application, End user and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The in-vitro diagnostics market size is estimated to be USD 109.5 billion in 2021 and is expected to witness a CAGR of 5.73% during the forecast period 2022-2029.
Companies Mentioned
The increasing geriatric population and the higher margins in the incidence of chronic and infectious diseases, rising acceptance of fully automated and point-of-care instruments in developed regions, growing awareness of disease diagnosis in developing regions, and escalating R&D investments by market players to launch the new IVD products expected to contribute the market growth.
However, unfavourable reimbursement scenario is expected to restrain the market growth.
Market Segmentation:
Product & Service (Revenue, USD Billion)
By Technology (Revenue, USD Billion)
By Application (Revenue, USD Billion)
By End user (Revenue, USD Billion)
By Region (Revenue, USD Billion)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/v89lxx
View source version on businesswire.com:https://www.businesswire.com/news/home/20221103005824/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/03/2022 08:54 AM/DISC: 11/03/2022 08:54 AM
http://www.businesswire.com/news/home/20221103005824/en